Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 44 | 44 | 44 | 44 | 44 |
| Gross Profit | 44 | 44 | 44 | 44 | 44 |
| Operating Expenses | 22,398 | 12,744 | 11,256 | 7,053 | 8,043 |
| Operating Income | -22,354 | -12,700 | -11,213 | -7,009 | -7,999 |
| Other Income | -71 | 1,074 | -2,770 | -3,676 | -5,806 |
| Pre-tax Income | -22,425 | -11,627 | -13,983 | -10,686 | -13,805 |
| Net Income Continuous | -22,420 | -11,627 | -13,983 | -10,686 | -13,805 |
| Minority Interests | 0 | 3 | -40 | -57 | -113 |
| Net Income | $-22,430 | $-11,629 | $-13,943 | $-10,628 | $-13,692 |
| EPS Basic Total Ops | -0.44 | -0.22 | -0.31 | -0.28 | -0.33 |
| EPS Basic Continuous Ops | -0.43 | -0.22 | -0.32 | -0.28 | -0.33 |
| EPS Diluted Total Ops | -0.44 | -0.22 | -0.31 | -0.28 | -0.33 |
| EPS Diluted Continuous Ops | -0.43 | -0.22 | -0.32 | -0.28 | -0.33 |
| EBITDA(a) | $-21,706 | $-12,277 | $-10,576 | $-6,578 | $-7,554 |